Clinical Trials Logo

Filter by:
NCT ID: NCT05836779 Completed - Cellulite Clinical Trials

A Study to Evaluate the Efficacy and Safety of CBL-514 in Participants With EFP; Cellulite (Stage 2)

Start date: May 10, 2023
Phase: Phase 2
Study type: Interventional

The Stage 2 of this phase 2 study is an open-label, single-arm study to assess the efficacy and safety of CBL-514 in participants with Edematous Fibrosclerotic Panniculopathy (EFP) cellulite.

NCT ID: NCT05836506 Completed - Healthy Volunteer Clinical Trials

A Study to Assess the Relative Bioavailability of Immediate Release Formulations of ABBV-903 in Healthy Adult Participants

Start date: April 18, 2023
Phase: Phase 1
Study type: Interventional

The main objective of this study is to assess the relative bioavailability and pharmacokinetics of ABBV-903 in healthy adult participants.

NCT ID: NCT05835388 Completed - Aging Clinical Trials

The South Texas Aging Registry and Repository

STARR
Start date: February 11, 2019
Phase:
Study type: Observational [Patient Registry]

This research registry and repository was designed because the investigators want to learn about how to improve the health and quality of life of older adults.

NCT ID: NCT05835323 Completed - Kidney Calculi Clinical Trials

Initial Clinical Experience With the MONARCH Platform, Urology for the Treatment of Kidney Stones

Start date: January 11, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to collect descriptive performance data using the MONARCH Platform, Urology (a novel robotic device) to perform mini-percutaneous nephrolithotomy (kidney stone removal) procedures. Data gathered from this study will be used to optimize the robotic platform and inform training and education material for the future users.

NCT ID: NCT05835180 Completed - Cirrhosis Clinical Trials

A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function

Start date: May 1, 2023
Phase: Phase 1
Study type: Interventional

The goal of this phase 1 study is to assess the pharmacokinetics, safety and tolerability following multiple oral doses of TVB-2640 in subjects with mild, moderate, or severe hepatic impairment compared to healthy subjects with normal hepatic function.

NCT ID: NCT05835063 Completed - Clinical trials for Heart Failure NYHA Class III

A Study to Improve Physician-Youth Communication and Medical Decision Making

CHATT
Start date: September 14, 2023
Phase: N/A
Study type: Interventional

The goal of this study is improving patient-centered communication for young people with advanced heart disease.

NCT ID: NCT05834036 Completed - Clinical trials for Antibiotic Enterocolitis

Effect of Antibiotics on Enteric Neurons and Glia

Start date: June 23, 2023
Phase: Phase 4
Study type: Interventional

The interactions between bacteria and their products with the intestinal tissue are important for maintaining a healthy and balanced system. Alterations in gut bacteria communities have been associated with various human pathologies. The investigators have found that mice treated with short and long-term antibiotics exhibit a transient yet profound loss of neurons in the more superficial submucosal and deeper muscularis plexi in the intestine accompanied by slow motility. Glia cells also depend on microbiota for their maintenance. In humans, antibiotic use has been associated with disorders of gut-brain interactions (DGBI) such as irritable bowel syndrome however whether there are changes in the enteric neurons and glia cells remain unknown. Therefore, the investigators propose to further characterize the neurons and glia populations in the human distal colon after a single antibiotic course. This study will reveal glia and neuronal subtypes that are susceptible to changes in the bacteria populations and depend on microbial products for their maintenance. These findings will guide future DGBI studies to ascertain the physiological effects that such loss has on intestinal healthy balance.

NCT ID: NCT05833789 Completed - Colonoscopy Clinical Trials

Visualization of the Colon Through Use of the Magnetic Flexible Endoscope (MFE)

Start date: October 12, 2023
Phase:
Study type: Observational

In this study, the investigators will evaluate the ability of the Magnetic Flexible Endoscope (MFE) to travel through the human colon. The MFE is a device made of ultra-flexible tubing that contains a camera, light, and magnet at the tip. The tip of the tube is about the size of a penny. The magnet inside the tip allows the MFE to be moved through the colon by a second magnet attached to a robotic arm that is outside the body. The objective of this feasibility study is to determine safety and tolerability of the Magnetic Flexible Endoscope (MFE) traveling in the human colon.

NCT ID: NCT05833490 Completed - Stroke Clinical Trials

The Effect of rPMS on Motor Skill Performance in Persons With a Stroke.

Start date: April 24, 2023
Phase: N/A
Study type: Interventional

In the past two decades, even as stroke cases increase around the world, advances in motor rehabilitation have been limited. Clinical trials of stroke rehabilitation have examined the therapeutic utility of several neuromodulatory devices to improve efficacy of motor training. However, there is limited knowledge on the effects of sensory-based priming techniques using repetitive peripheral magnetic stimulation (rPMS) post stroke. This project focuses on understanding the effect of rPMS on motor skill performance in persons with stroke.

NCT ID: NCT05833022 Completed - Sickle Cell Disease Clinical Trials

Patient Characteristics and Treatment Patterns From Early Crizanlizumab Use in Real-world Setting: Preliminary Analysis From Select Sickle Cell Centers

Start date: July 30, 2021
Phase:
Study type: Observational

This was a retrospective cohort study using secondary data from member sites of the National Alliance of Sickle Cell Centers (NASCC) with at least five patients who initiated crizanlizumab. Patients who were prescribed crizanlizumab were included in the cohort.